In the second chunky biotech raising so far this year, PYC Therapeutics is seeking $650 million via a placement and ... Read ...
Glaukos (GKOS) is back in focus after the U.S. FDA approved a labeling update for its iDose TR glaucoma therapy, allowing repeat administration under a defined protocol backed by safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results